-
1 Comment
MagForce AG is currently in a long term downtrend where the price is trading 10.9% below its 200 day moving average.
From a valuation standpoint, the stock is 92.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 101.3.
Based on the above factors, MagForce AG gets an overall score of 1/5.
| Exchange | F |
|---|---|
| CurrencyCode | EUR |
| Sector | |
| Industry | |
| ISIN | DE000A0HGQF5 |
| Target Price | 11 |
|---|---|
| Dividend Yield | 0.0% |
| Market Cap | 359K |
| PE Ratio | 0.02 |
| Beta | 3.02 |
MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of brain tumors; NanoPlan, a software that supports the attending physician in preparing the ideal treatment plan for the NanoTherm therapy; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MF6.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
